Real-time Success

Real-time Success When Time Is of the Essence

Reliable qPCR When Your Results Matter Most

Accelerating your infectious disease research and assay development

Whether used for research in variant classification and detection, environmental surveillance, or epidemiological studies, assay development for infectious diseases is not just important work, but also time-sensitive. These considerations are why researchers rely on quantitative (qPCR) and quantitative reverse transcriptase PCR (qRT-PCR) for viral and bacterial pathogen assay development—and why your choice of qRT-PCR reagents is critical.

The Agilent qPCR and qRT-PCR portfolio provides you with easy, end-to-end solutions to help you accelerate your infectious disease research when you need results quickly. Read on to see how your lab can benefit from:

High-performance reagents: increase confidence in your results with sensitive, specific, and reproducible reagents
Easily scalable solutions: tailor your workflows to your lab’s throughput
Quick workflows and rapid turnaround times: get your results faster when time is of the essence with rapid cycling times

Read on to see an exciting example from researchers in the community developing a qRT-PCR-based assay for SARS-CoV-2 environmental surveillance!

Watch the webinar to see how researchers developed a qPCR-based SARS-CoV-2 analysis protocol

Watch now

Developing a SARS-CoV-2 analysis protocol for wastewater

Over the span a few short months, SARS-CoV-2 has grown from a newly discovered class of coronavirus to the confirmed infectious agent of a worldwide pandemic. Outbreaks can occur suddenly and, when they do, can overwhelm hospitals and intensive care units (ICUs). However, by monitoring SARS-CoV-2 in wastewater using a qPCR assay, researchers are providing data that can help develop predictive modeling tools for occupancy trends to allow healthcare institutions to better predict potential surges.

In this webinar, Agustin Pierri, PhD, Technical Director of Weck Laboratories (Los Angeles, CA) will highlight how researchers in his laboratory used qRT-PCR to develop a SARS-CoV-2 assay, cover the benefits of this approach in infectious disease assay development, and touch on how qRT-PCR may be used for research and detection of other pathogens.

Learn more about qPCR and qRT-PCR and associated applications

qPCR Mini Catalog

Download the qPCR mini catalog for a complete overview of our product range.

Download now

The Need for Speed

The rate of spread of a pandemic depends on two things: how many people each case infects, and how long it takes for the infection to spread between people.

Discover more

Compare reagents

Still trying to decide on a qPCR kit? See how a variety of master mixes performed—and which one came out on top.

Learn more

Virtual demo

Tour the features of the AriaMx real-time PCR system with the virtual demo

Play video

For Research Use Only. Not for use in diagnostic procedures.

Agilent products are NOT approved for COVID-19 testing, diagnosis, treatment, or mitigation. Agilent has not validated a product to detect the novel coronavirus.